⌘K

Home/Filings/4/0001735276-26-000005

4//SEC Filing

Arbuckle Stuart A 4

Accession 0001735276-26-000005

CIK 0001178670other

View on SEC.gov Company Profile

Filed

Jan 6, 7:00 PM ET

Accepted

Jan 7, 4:17 PM ET

Size

5.4 KB

Accession

0001735276-26-000005

Insider Transaction Report

Form 4

Period: 2026-01-05

ALNYLAM PHARMACEUTICALS, INC.ALNY

Arbuckle Stuart A

Director

Transactions

Award
Stock Option (right to buy)
2026-01-05+3,279→ 3,279 total
Exercise: $397.83Exp: 2036-01-05→ Common Stock (3,279 underlying)

Footnotes (1)

[F1]The stock option will vest as to one third of the shares on each of the first, second and third anniversaries of the date of grant.

Documents

1 file

4
edgardoc.xmlPrimary
PRIMARY DOCUMENT

Issuer

ALNYLAM PHARMACEUTICALS, INC.

CIK 0001178670

Entity typeother

Related Parties

1

filerCIK 0001557290

Filing Metadata

Form type: 4
Filed: Jan 6, 7:00 PM ET
Accepted: Jan 7, 4:17 PM ET
Size: 5.4 KB

View on SEC.gov